-
Symbol
-
LIMN on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $ 0.0001 per share
-
Latest Disclosed Shares Owned
-
6,169,406 shares
-
Security Ownership %
-
24%
Valetudo Therapeutics LLC ownership in Liminatus Pharma, Inc. Common Stock, par value $ 0.0001 per share (LIMN)
07 May 2025 - Valetudo Therapeutics LLC has filed an SCHEDULE 13D form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,169,406 shares of Liminatus Pharma, Inc. Common Stock, par value $ 0.0001 per share (LIMN).
This represents 24% ownership of the company.
This is the first filing by Valetudo Therapeutics LLC disclosing ownership of Liminatus Pharma, Inc. Common Stock, par value $ 0.0001 per share (LIMN).